HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful thyrotropin-releasing hormone therapy for emotional incontinence and amnesia resulting from mumps encephalitis.

Abstract
A healthy 7-year-old girl developed emotional incontinence and amnesia associated with mumps encephalitis. Her neurologic findings markedly improved after treatment of daily injection of thyrotropin-releasing hormone tartrate without any adverse effects. Although magnetic resonance imaging revealed no abnormal findings, the findings of Tc-hexamethylpropyleneamine oxime single photon emission computed tomography demonstrated abnormality of left temporooccipital area thought to be responsible for her symptoms.
AuthorsTomohiro Kubo, Osamu Kobayashi, Masatoshi Nozaki, Takayuki Kurokawa, Kikuko Tamura, Shigeaki Nonoyama
JournalThe Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 23 Issue 12 Pg. 1175-6 (Dec 2004) ISSN: 0891-3668 [Print] United States
PMID15626965 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Technetium Tc 99m Exametazime
  • Thyrotropin-Releasing Hormone
Topics
  • Affective Symptoms (drug therapy)
  • Amnesia (drug therapy)
  • Child
  • Encephalitis, Viral (complications)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Mumps (complications)
  • Technetium Tc 99m Exametazime
  • Thyrotropin-Releasing Hormone (therapeutic use)
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: